Breaking News
Top News
-
US Live Nation and Ticketmaster verdict triggers calls for Australian investigation into ticketing rules
-
Jacinta Allan wants voters to see Victoria’s 12-year-old Labor government as ‘new and united’. Can she cling to power?
-
NSW should think twice before banning ‘globalise the intifada’ after court struck down anti-protest law, legal expert says
-
EU prepares for jet fuel sharing as supplies dwindle
-
The AI Leadership Imperative
-
Ariel’s Rogers on Investing in Women’s Sports
-
Gold Jumps to One-Month High as Iran Says Hormuz Completely Open
-
Lumina Metals, Shareholder Seek $251 Million in Toronto IPO
-
France and Greece to Renew Defense Pact and Broaden Cooperation
-
Iran Conflict Poses Risk to Global Economy, IMF Members to Say
-
Bitcoin Climbs to Two-Month High Amid Middle East Deal Optimism
-
San Diego Padres Nearing Deal to be Sold for an MLB-Record $3.9 Billion
-
Gwyneth Paltrow Is Bringing Her Takeout Business to New York City
-
‘Feed the People!’ Review: In Praise of the Supermarket
-
It’s not just gas prices. How the Iran war is coming for your grocery bill.
-
B. Riley Sees Upside in MacroGenics, Inc. (MGNX) Following Gilead-Driven Sector Activity
-
Wolfe Highlights Differentiation Potential in Palisade Bio, Inc. (PALI) Clinical Profile
-
Evercore Adjusts Fortrea Holdings Inc. (FTRE) Valuation Following Updated Near-Term Assumptions
-
Jefferies Sees Reduced Visibility for Replimune Group, Inc. (REPL) Following FDA Decision
-
Northland Highlights ARS Pharmaceuticals, Inc. (SPRY) Needle-Free Therapy as Major Innovation Driver
2026-02-05


































